| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3378308 | Journal of Microbiology, Immunology and Infection | 2010 | 5 Pages |
Abstract
Chronic disseminated candidiasis is a complication of the intensive therapies of hematological malignancies revealed during hematopoietic recovery, a context reminiscent of the immune restoration inflammatory syndrome in human immunodeficiency virus patients receiving antiretroviral therapy. We report a case of severe exacerbation of chronic disseminated candidiasis after pegylated granulocyte-colony stimulating factor administration. We emphasize the major inflammatory substrate of the disease and suggest that immune-modulating strategies such as hematopoietic growth factors, should be used cautiously in such patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
